JP2021519599A5 - - Google Patents

Info

Publication number
JP2021519599A5
JP2021519599A5 JP2020554527A JP2020554527A JP2021519599A5 JP 2021519599 A5 JP2021519599 A5 JP 2021519599A5 JP 2020554527 A JP2020554527 A JP 2020554527A JP 2020554527 A JP2020554527 A JP 2020554527A JP 2021519599 A5 JP2021519599 A5 JP 2021519599A5
Authority
JP
Japan
Prior art keywords
ospa
antigenic
polypeptide
serotype
antigenic ospa
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2020554527A
Other languages
English (en)
Japanese (ja)
Other versions
JP2021519599A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/025367 external-priority patent/WO2019195276A1/en
Publication of JP2021519599A publication Critical patent/JP2021519599A/ja
Publication of JP2021519599A5 publication Critical patent/JP2021519599A5/ja
Priority to JP2024002941A priority Critical patent/JP2024038345A/ja
Pending legal-status Critical Current

Links

JP2020554527A 2018-04-03 2019-04-02 抗原性ospaポリペプチド Pending JP2021519599A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024002941A JP2024038345A (ja) 2018-04-03 2024-01-12 抗原性ospaポリペプチド

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862652210P 2018-04-03 2018-04-03
US62/652,210 2018-04-03
PCT/US2019/025367 WO2019195276A1 (en) 2018-04-03 2019-04-02 Antigenic ospa polypeptides

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024002941A Division JP2024038345A (ja) 2018-04-03 2024-01-12 抗原性ospaポリペプチド

Publications (2)

Publication Number Publication Date
JP2021519599A JP2021519599A (ja) 2021-08-12
JP2021519599A5 true JP2021519599A5 (cg-RX-API-DMAC7.html) 2022-04-07

Family

ID=66397424

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2020554527A Pending JP2021519599A (ja) 2018-04-03 2019-04-02 抗原性ospaポリペプチド
JP2024002941A Pending JP2024038345A (ja) 2018-04-03 2024-01-12 抗原性ospaポリペプチド

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024002941A Pending JP2024038345A (ja) 2018-04-03 2024-01-12 抗原性ospaポリペプチド

Country Status (7)

Country Link
US (2) US11993636B2 (cg-RX-API-DMAC7.html)
EP (1) EP3773697A1 (cg-RX-API-DMAC7.html)
JP (2) JP2021519599A (cg-RX-API-DMAC7.html)
KR (2) KR20260077937A (cg-RX-API-DMAC7.html)
CN (1) CN112584858A (cg-RX-API-DMAC7.html)
CA (1) CA3095174A1 (cg-RX-API-DMAC7.html)
WO (1) WO2019195276A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3534941A4 (en) * 2016-11-07 2020-07-08 The Wistar Institute Of Anatomy And Biology CONSTRUCTIONS OF ANTI-DNA ANTIBODIES FOR USE AGAINST LYME DISEASE
JP7614841B2 (ja) 2018-04-03 2025-01-16 サノフイ 抗原性呼吸器合胞体ウイルスポリペプチド
CN112512566A (zh) 2018-04-03 2021-03-16 赛诺菲 抗原性爱泼斯坦-巴尔病毒多肽
EP3773698A1 (en) 2018-04-03 2021-02-17 Sanofi Ferritin proteins
CN111217919B (zh) * 2020-03-04 2020-12-01 中山大学 一种基于火球菌铁蛋白的新型冠状病毒s蛋白双区域亚单位纳米疫苗
CN111217918B (zh) * 2020-03-04 2020-11-10 中山大学 一种基于2,4-二氧四氢喋啶合酶的新型冠状病毒s蛋白双区域亚单位纳米疫苗
WO2023044016A2 (en) * 2021-09-17 2023-03-23 Cspc Dophen Corporation Antibody immune-stimulant conjugates and use thereof
CA3242439A1 (en) 2021-12-17 2023-06-22 Sanofi Lyme disease rna vaccine
WO2023214082A2 (en) 2022-05-06 2023-11-09 Sanofi Signal sequences for nucleic acid vaccines
CN114736293B (zh) * 2022-06-14 2022-09-02 中国农业科学院生物技术研究所 SARS-CoV-2中和性纳米抗体、自组装铁蛋白融合纳米抗体及制备方法和应用
JP2026525284A (ja) * 2023-07-10 2026-07-29 ダイナヴァックス テクノロジーズ コーポレイション アジュバントおよびborrelia細胞表層タンパク質a抗原を含むライム病ワクチン
EP4743110A1 (en) * 2023-07-10 2026-05-20 Dynavax Technologies Corporation Lyme disease vaccines containing an adjuvant and Borrelia outer surface protein A and C antigens
WO2026132296A2 (en) * 2024-12-20 2026-06-25 Bavarian Nordic A/S Multimeric lyme disease antigen particles

Family Cites Families (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2057536C (en) * 1990-12-21 1999-10-26 John J. Dunn Cloning and expression of borrelia lipoproteins
US6239116B1 (en) 1994-07-15 2001-05-29 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
US6429199B1 (en) 1994-07-15 2002-08-06 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules for activating dendritic cells
AU713040B2 (en) 1994-07-15 1999-11-18 University Of Iowa Research Foundation, The Immunomodulatory oligonucleotides
US6207646B1 (en) 1994-07-15 2001-03-27 University Of Iowa Research Foundation Immunostimulatory nucleic acid molecules
CA2281838A1 (en) 1997-02-28 1998-09-03 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated cpg dinucleotide in the treatment of lps-associated disorders
US6406705B1 (en) 1997-03-10 2002-06-18 University Of Iowa Research Foundation Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
EP1003531B1 (en) 1997-05-20 2007-08-22 Ottawa Health Research Institute Processes for preparing nucleic acid constructs
US6218371B1 (en) 1998-04-03 2001-04-17 University Of Iowa Research Foundation Methods and products for stimulating the immune system using immunotherapeutic oligonucleotides and cytokines
WO2001075436A1 (en) 2000-04-03 2001-10-11 Board Of Trustees Of The Leland Stanford Junior University A method for protein structure alignment
EP1311540B1 (en) * 2000-08-18 2007-12-19 Research Foundation Of State University Of New York Altered ospa of borrelia burgdorferi
US7097841B2 (en) * 2002-05-10 2006-08-29 New Century Pharmaceuticals, Inc. Ferritin fusion proteins for use in vaccines and other applications
US7774185B2 (en) 2004-09-14 2010-08-10 International Business Machines Corporation Protein structure alignment using cellular automata
US20100285051A1 (en) 2007-12-21 2010-11-11 Dominique Ingrid Lemoine Vaccine
US20110117131A1 (en) * 2008-04-09 2011-05-19 Ning Huang Production of OspA for Lyme Disease Control
CZ301541B6 (cs) * 2008-06-25 2010-04-07 Biologické centrum AV CR, v.v.i., Parazitologický ústav Feritin 2 pro imunizaci organismu proti klíštatum
US8623375B2 (en) * 2010-05-14 2014-01-07 Baxter International Inc. Chimeric OspA genes, proteins, and methods of use thereof
US20140186371A1 (en) 2011-04-07 2014-07-03 Guriqbal S. Basi Compositions and methods for treating diseases of protein aggregation involving ic3b deposition
JP5795184B2 (ja) 2011-04-22 2015-10-14 国立大学法人 奈良先端科学技術大学院大学 被検物質の電気化学的検出方法
EP2515112B1 (en) 2011-04-22 2015-08-12 Sysmex Corporation Method for electrochemically detecting analyte
EP2877205A4 (en) 2012-07-26 2016-04-06 Jackson H M Found Military Med VACCINE WITH A MULTIMED FUSION PROTEIN AND IMMUNOTHERAPY
CZ2014320A3 (cs) * 2014-05-09 2015-11-18 VÝZKUMNÝ ÚSTAV VETERINÁRNÍHO LÉKAŘSTVÍ, v.v.i. Polyepitopový antigen, vakcinační konstrukt a vakcína pro prevenci lymeské boreliózy
US10363301B2 (en) * 2014-05-27 2019-07-30 The United States Of America As Represented By The Secretary, Department Of Health And Human Services Stabilized influenza hemagglutinin stem region trimers and uses thereof
US9703095B2 (en) 2015-01-05 2017-07-11 Edward Pakhchyan Light modulator for MEMS display
US10301377B2 (en) * 2015-02-24 2019-05-28 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Middle east respiratory syndrome coronavirus immunogens, antibodies, and their use
MX2018006785A (es) 2015-12-04 2018-11-09 Dana Farber Cancer Inst Inc Vacunacion con el dominio alfa 3 de mica/b para el tratamiento del cancer.
KR102724939B1 (ko) 2016-06-17 2024-11-01 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 선형 또는 분지형 폴리아크릴산 폴리머 아쥬반트를 포함하는 신규한 면역원성 제형
EP3612562A2 (en) 2017-04-19 2020-02-26 Institute for Research in Biomedicine Plasmodium sporozoite npdp peptides as vaccine and target novel malaria vaccines and antibodies binding to
MA50813A (fr) 2017-11-21 2020-09-30 Modernatx Inc Vaccins contre le virus d'epstein-barr

Similar Documents

Publication Publication Date Title
US12162907B2 (en) Subunit vaccine for treatment or prevention of a respiratory tract infection
JP2010162023A5 (cg-RX-API-DMAC7.html)
CN107847580B (zh) 针对rsv的疫苗
JP2012501959A5 (cg-RX-API-DMAC7.html)
JP2008529558A5 (cg-RX-API-DMAC7.html)
CA2759583C (en) A tuberculosis tb vaccine to prevent reactivation
JP2023506765A5 (cg-RX-API-DMAC7.html)
JP2009544333A5 (cg-RX-API-DMAC7.html)
JP2008530245A5 (cg-RX-API-DMAC7.html)
JP2013507907A5 (cg-RX-API-DMAC7.html)
JP2014507146A5 (cg-RX-API-DMAC7.html)
JP2019163253A5 (cg-RX-API-DMAC7.html)
JP2010500399A5 (cg-RX-API-DMAC7.html)
CN1610697A (zh) 戊型肝炎病毒单克隆抗体或其结合活性片段及其用途
JP2014503172A5 (cg-RX-API-DMAC7.html)
HRP20170094T1 (hr) Imunogeni pripravak
HRP20120331T1 (hr) Postupak sprječavanja ili liječenja infekcije bakterijom m. tuberculosis
JP2009515831A5 (cg-RX-API-DMAC7.html)
JP2016514713A5 (cg-RX-API-DMAC7.html)
JP2004526405A5 (cg-RX-API-DMAC7.html)
JP2016504993A5 (cg-RX-API-DMAC7.html)
JP2021506824A5 (cg-RX-API-DMAC7.html)
HRP20130022T1 (hr) Fuzijski proteini koji sadrže antigene ny-eso-1 i lage-1 za odbacivanje tumora
JP2006506097A5 (cg-RX-API-DMAC7.html)
JP2012506699A5 (cg-RX-API-DMAC7.html)